An observational study in Horner's Syndrome, sponsored by Soonchunhyang University Hospital. Completed at 1 site in Korea, Republic of. Open to female participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2014-05-05.
Sponsored by Soonchunhyang University Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study prospectively evaluates the incidence of Horner's syndrome after thoracic epidural anesthesia following continuous thoracic epidural analgesia for mastectomy. The incidence was 1.36% and the mechanism of Horner's syndrome was cephalic spread of the local anesthetic.
Transient Horner's syndrome has been recognized rare complication of epidural anesthesia and the incidence is not exactly well-known in thoracic epidural anesthesia. Therefore, this study prospectively evaluates the incidence of Horner's syndrome after thoracic epidural anesthesia following continuous thoracic epidural analgesia for mastectomy.
Six hundred thirty three Patients, who scheduled for mastectomy with/without breast reconstruction, were eligible for this prospective observational study from September 2010 to December 2013. Thoracic epidural anesthesia performed using 0.375% or 0.5% ropivacaine 15mL followed by sedation consisting of propofol without muscle relaxation. After the operation, thoracic epidural analgesia continued; supplemented by a continuous epidural infusion of ropivacaine 0.15%, 2 ml/h with fentanyl 8mcg/h. At 1 hour, 2hour, 1 day, 2 day and 3 day after the operation, postoperative surveillance consisted of the occurrence of symptoms of Horner's syndrome (miosis, ptosis, and hyperemia) were performed by anesthesiologists.
Soonchunhyang University Hospital is the lead sponsor of 61 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients, who scheduled for mastectomy with/without breast reconstruction
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
thoracic epidural anesthesia following continuous thoracic epidural analgesia for mastectomy
Procedure: thoracic epidural anesthesia · Procedure: mastectomy · Drug: Ropivacaine · Drug: Propofol · Drug: Fentanyl
thoracic epidural anesthesia following continuous thoracic epidural analgesia for mastectomy
mastectomy with/without breast reconstruction
Thoracic epidural anesthesia performed using 0.375% or 0.5% ropivacaine
Thoracic epidural anesthesia performed followed by sedation consisting of propofol
thoracic epidural analgesia continued; supplemented by a continuous epidural infusion of ropivacaine 0.15%, 2 ml/h with fentanyl 8mcg/h.
Number of Participants with Horner's syndrome
Time frame: 3 day after the operation
Number of Participants with back pain
Time frame: 3 day after the operation
Number of Participants with radiating symptoms
segmental pain or paresthesia corresponded to a dermatome of epidural block spinal root
Time frame: 3 day after the operation
Number of Participants with numbness
Time frame: 3 day after the operation
Number of Participants with muscular weakness
Time frame: 3 day after the operation
The record gives a start of Sep 2010, a primary completion of Dec 2013 and a completion of Apr 2014. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Horner Syndrome
Soonchunhyang University Hospital